2019 Wiskott-Aldrich Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 46 pages | ID: 2480B612F3BEN
VPAResearch

Abstracts

The global clinical trial report- “2019 Wiskott-Aldrich Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Wiskott-Aldrich Syndrome. It presents in-depth analysis of Wiskott-Aldrich Syndrome clinical trials across markets and companies. The research work is for providing complete understanding into trends in Wiskott-Aldrich Syndrome.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Wiskott-Aldrich Syndrome clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Wiskott-Aldrich Syndrome

The research work is prepared through extensive and continuous research on Wiskott-Aldrich Syndrome trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Wiskott-Aldrich Syndrome patients are identified
• The report includes panorama of Wiskott-Aldrich Syndrome clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Wiskott-Aldrich Syndrome clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Wiskott-Aldrich Syndrome Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Wiskott-Aldrich Syndrome Clinical Trials by Region
  2.2.2 Average Enrollment of Wiskott-Aldrich Syndrome Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Wiskott-Aldrich Syndrome Treatment, 2019

3. REGION WISE WISKOTT-ALDRICH SYNDROME CLINICAL TRIALS

3.1 Asia Pacific Wiskott-Aldrich Syndrome Clinical Trials by Country
3.2 Europe Wiskott-Aldrich Syndrome Clinical Trials by Country
3.3 North America Wiskott-Aldrich Syndrome Clinical Trials by Country
3.4 Middle East and Africa Wiskott-Aldrich Syndrome Clinical Trials by Country
3.5 South and Central America Wiskott-Aldrich Syndrome Clinical Trials by Country

4. WISKOTT-ALDRICH SYNDROME CLINICAL TRIAL TRENDS

4.1 Start Year wise Wiskott-Aldrich Syndrome Clinical Trials
4.2 Phase wise Wiskott-Aldrich Syndrome Clinical Trials
4.3 Trial Status wise Wiskott-Aldrich Syndrome Clinical Trials
4.4 Trial Type wise Wiskott-Aldrich Syndrome Clinical Trials

5. WISKOTT-ALDRICH SYNDROME AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Wiskott-Aldrich Syndrome Trials by Year
5.2 Average Enrollment in Wiskott-Aldrich Syndrome Trials by Phase
5.3 Average Enrollment in Wiskott-Aldrich Syndrome Trials by Status
5.4 Average Enrollment in Wiskott-Aldrich Syndrome Trials by Type of Trial

6. COMPANIES PARTICIPATING IN WISKOTT-ALDRICH SYNDROME CLINICAL TRIALS

6.1 Wiskott-Aldrich Syndrome Trials by Sponsor Type
6.2 Wiskott-Aldrich Syndrome Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Wiskott-Aldrich Syndrome Trials- Phase
7.2 Wiskott-Aldrich Syndrome Trials- Phase
7.3 Wiskott-Aldrich Syndrome Trials- Phase
7.4 Wiskott-Aldrich Syndrome Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Wiskott-Aldrich Syndrome Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Wiskott-Aldrich Syndrome Clinical Trials and Enrolment
Figure 5: Europe – Country wise Wiskott-Aldrich Syndrome Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Wiskott-Aldrich Syndrome Clinical Trials and Enrolment
Figure 7: North America – Country wise Wiskott-Aldrich Syndrome Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Wiskott-Aldrich Syndrome Clinical Trials and Enrolment
Figure 9: Wiskott-Aldrich Syndrome Clinical Trials by Phase
Figure 10: Wiskott-Aldrich Syndrome Clinical Trials by Trial Status
Figure 11: Wiskott-Aldrich Syndrome Clinical Trials by Type
Figure 12: Wiskott-Aldrich Syndrome Clinical Trials by Sponsor Type
Figure 13: Wiskott-Aldrich Syndrome Clinical Trials by Leading Sponsors
Figure 14: Wiskott-Aldrich Syndrome Average Enrollment by Phase
Figure 15: Wiskott-Aldrich Syndrome Average Enrollment by Trial Status
Figure 16: Wiskott-Aldrich Syndrome Average Enrollment by Type
Figure 17: Wiskott-Aldrich Syndrome- Average Enrolment by Type of Sponsors
Figure 18: Wiskott-Aldrich Syndrome- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Wiskott-Aldrich Syndrome Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Wiskott-Aldrich Syndrome Clinical Trials and Enrolment
Table 5: Europe – Country wise Wiskott-Aldrich Syndrome Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Wiskott-Aldrich Syndrome Clinical Trials and Enrolment
Table 7: North America – Country wise Wiskott-Aldrich Syndrome Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Wiskott-Aldrich Syndrome Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Wiskott-Aldrich Syndrome Average Enrollment by Phase
Table 15: Wiskott-Aldrich Syndrome Average Enrollment by Trial Status
Table 16: Wiskott-Aldrich Syndrome Average Enrollment by Type
Table 17: Wiskott-Aldrich Syndrome- Average Enrolment by Type of Sponsors
Table 18: Wiskott-Aldrich Syndrome- Enrolment by Leading Sponsors